Amyris Announces Proposed Public Offering (Secondary And Primary) Of Common Stock
News provided by
Share this article
Share this article
EMERYVILLE, Calif., April 7, 2021 /PRNewswire/ Amyris, Inc. (Nasdaq: AMRS) ( Amyris ), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the commencement of a proposed underwritten public offering of shares of its common stock.
Amyris is conducting a resale of stock on behalf of its current stockholders, DSM International B.V. and affiliates of Vivo Capital LLC (the selling stockholders). The selling stockholders intend to offer an aggregate of $150.0 million of shares of Amyris s common stock. Amyris will not receive any proceeds from the sale of the shares by the selling stockholders. Additionally, Amyris intends to offer $100.0 million of shares of its common stock to support its continued growth.
Amyris to Present at Cowen's 2nd Annual Consumer Platforms for the Next Generation Summit on April 6, 2021 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer.
Share this article
Share this article
EMERYVILLE, Calif., Dec. 16, 2020 /PRNewswire/ Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, successfully hosted the first session of its virtual investor mini-series themed Delivering on the Promise of Synthetic Biology.
This first session entitled
Science and Technology, Sustainable Solutions for a Healthier Planet was conducted via live webcast and teleconference yesterday, Tuesday, December 15, 2020 at 1:00pm ET (10:00 am PT). The session included a business update, a technology presentation and Q&A.
The webinar was well-attended with nearly 300 people participating. Speaking on behalf of Amyris during the event were John Melo, President and Chief Executive Officer; Han Kieftenbeld, Chief Financial Officer, and; Sunil Chandran, Senior Vice President, Research and Development